To investigate the effect of AXL inhibition on CARTs in vivo, mice were inoculated with Jeko tumor cells, treated with CD19-directed CARTs in combination with or without TP0903 and rechallenged with Jeko cells. The gene discussed is AXL; the disease is neoplasm.